XML 101 R89.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities $ 19,726 $ 40,714
Cash flows from investing activities:    
Sale of investment securities 7,759 2,357
Maturities of investment securities 11,308 8,112
Purchase of investment securities (20,623) (4,364)
Investments in real estate ventures (871) (533)
Purchase of subsidiaries (668) 0
Distributions from investments in real estate ventures 1,134 219
Increase in cash surrender value of life insurance policies (238) (36)
Increase in restricted assets (7) (4)
Investments in subsidiaries 0 0
Capital expenditures (3,825) (3,987)
Repayments of notes receivable 0 32
Pay downs of investment securities 258 446
Investments in real estate, net (641) (355)
Net cash (used in) provided by investing activities (6,414) 1,887
Cash flows from financing activities:    
Repayments of debt (230,466) (490)
Borrowings under revolver 94,400 55,170
Repayments on revolver (87,420) (61,728)
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (60,459) (57,187)
Distributions to non-controlling interest (285) 0
Net cash used in financing activities (284,230) (64,235)
Net decrease in cash, cash equivalents and restricted cash (270,918) (21,634)
Cash, cash equivalents and restricted cash, beginning of period 591,729 310,937
Cash, cash equivalents and restricted cash, end of period 320,811 289,303
Consolidating Adjustments    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities (64,089) (43,154)
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Investments in real estate ventures 0 0
Purchase of subsidiaries 0  
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies 0 0
Increase in restricted assets 0 0
Investments in subsidiaries 1,794 605
Capital expenditures 0 0
Repayments of notes receivable   (20,000)
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities 1,794 (19,395)
Cash flows from financing activities:    
Repayments of debt 0 20,000
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received (1,794) (605)
Intercompany dividends paid 64,089 43,154
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0  
Net cash used in financing activities 62,295 62,549
Net decrease in cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Parent/Issuer | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 22,468 18,670
Cash flows from investing activities:    
Sale of investment securities 7,759 2,357
Maturities of investment securities 11,308 8,112
Purchase of investment securities (20,623) (4,364)
Investments in real estate ventures 0 0
Purchase of subsidiaries 0  
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies 38 11
Increase in restricted assets (7) (4)
Investments in subsidiaries (1,794) (605)
Capital expenditures 0 (5)
Repayments of notes receivable   20,000
Pay downs of investment securities 258 446
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (3,061) 25,948
Cash flows from financing activities:    
Repayments of debt (230,000) 0
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (60,459) (57,187)
Distributions to non-controlling interest 0  
Net cash used in financing activities (290,459) (57,187)
Net decrease in cash, cash equivalents and restricted cash (271,052) (12,569)
Cash, cash equivalents and restricted cash, beginning of period 474,880 194,719
Cash, cash equivalents and restricted cash, end of period 203,828 182,150
Subsidiary Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities 72,093 74,867
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Investments in real estate ventures 0 0
Purchase of subsidiaries 0  
Distributions from investments in real estate ventures 0 0
Increase in cash surrender value of life insurance policies (276) (47)
Increase in restricted assets 0 0
Investments in subsidiaries 0 0
Capital expenditures (1,638) (911)
Repayments of notes receivable   0
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (1,914) (958)
Cash flows from financing activities:    
Repayments of debt (372) (20,422)
Borrowings under revolver 94,400 55,170
Repayments on revolver (87,420) (61,728)
Capital contributions received 400 350
Intercompany dividends paid (52,589) (40,119)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest 0  
Net cash used in financing activities (45,581) (66,749)
Net decrease in cash, cash equivalents and restricted cash 24,598 7,160
Cash, cash equivalents and restricted cash, beginning of period 23,849 20,175
Cash, cash equivalents and restricted cash, end of period 48,447 27,335
Subsidiary Non-Guarantors | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by operating activities (10,746) (9,669)
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Investments in real estate ventures (871) (533)
Purchase of subsidiaries (668)  
Distributions from investments in real estate ventures 1,134 219
Increase in cash surrender value of life insurance policies 0 0
Increase in restricted assets 0 0
Investments in subsidiaries 0 0
Capital expenditures (2,187) (3,071)
Repayments of notes receivable   32
Pay downs of investment securities 0 0
Investments in real estate, net (641) (355)
Net cash (used in) provided by investing activities (3,233) (3,708)
Cash flows from financing activities:    
Repayments of debt (94) (68)
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 1,394 255
Intercompany dividends paid (11,500) (3,035)
Dividends and distributions on common stock 0 0
Distributions to non-controlling interest (285)  
Net cash used in financing activities (10,485) (2,848)
Net decrease in cash, cash equivalents and restricted cash (24,464) (16,225)
Cash, cash equivalents and restricted cash, beginning of period 93,000 96,043
Cash, cash equivalents and restricted cash, end of period $ 68,536 $ 79,818